Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
NEN | Just announced vote on capital return and winding up | 01/08/24 | 42 | 22K | |||
|
|||||||
NEN | June Quarter 2020 NTA | 14/04/21 | 48 | 15K | |||
|
|||||||
NEN | NTA 31/3/20 | 27/07/20 | 36 | 9.6K | |||
|
|||||||
NEN | Is there any information out there? | 10/06/19 | 11 | 8.5K | |||
|
|||||||
NEN | NTA 30/6 | 14/01/19 | 13 | 7.1K | |||
|
|||||||
NEN | win/win | 30/11/18 | 26 | 13K | |||
|
|||||||
NEN | Sinful | 16/07/17 | 17 | 9.1K | |||
|
|||||||
NEN | Ann: Neon Capital Post Delisted Contacts | 05/05/17 | 17 | 10K | |||
|
See All Discussions